| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.2M | -28.4% |
| SG&A Expense | $9.5M | -16.1% |
| Operating Income | -$27.2M | +23.2% |
| Interest Expense | $2.1M | +110.5% |
| Pre-tax Income | -$28.3M | +21.9% |
| Income Tax | $65K | -3.0% |
| Net Income | -$28.3M | +21.8% |
| EPS (Basic) | $0.95 | -31.7% |
| EPS (Diluted) | $0.95 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.3M | -49.5% |
| Short-term Investments | $2.0M | — |
| Accounts Receivable | $50K | — |
| Current Assets | $36.9M | -44.7% |
| Total Assets | $45.5M | -41.6% |
| Current Liabilities | $7.9M | -28.1% |
| Long-term Debt | $15.0M | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.1M | -5.5% |
| Capital Expenditures | $112K | -97.0% |
| Investing Cash Flow | -$2.1M | -113.0% |
| Financing Cash Flow | $292K | -99.2% |
| Free Cash Flow | -$29.2M | +6.6% |
| -31.7% |
| Stockholders' Equity |
| $21.0M |
| -55.7% |